SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-260668
Filing Date
2010-11-15
Accepted
2010-11-15 16:16:39
Documents
4
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d10q.htm 10-Q 865226
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6449
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6444
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 5797
  Complete submission text file 0001193125-10-260668.txt   885530
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 101192635
SIC: 2835 In Vitro & In Vivo Diagnostic Substances